Passage Bio to Merge with Remix Therapeutics in Deal Valued at $90 Million
Passage Bio has executed an amended and restated agreement with Remix Therapeutics, accelerating the previously announced merger and.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day